je.st
news
Microlin Bio buys Marina Biotech's nucleic acid therapeutics assets in cash-and-stock deal
2016-03-16 19:30:38| Biotech - Topix.net
Microlin Bio and Marina Biotech execute a term sheet under which Microlin intends to acquire Marina's nucleic acid therapeutics assets for 6.7M shares of Microlin stock and ~$1M in cash. Based on the recent price of $1.50 per share of MICB, the deal is valued at slightly more than $11M.
Tags: deal
acid
bio
assets
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||